Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/112403
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amaral, Maria João | - |
dc.contributor.author | Oliveira, Rui C. | - |
dc.contributor.author | Donato, Paulo | - |
dc.contributor.author | Tralhão, José Guilherme | - |
dc.date.accessioned | 2024-01-31T11:24:12Z | - |
dc.date.available | 2024-01-31T11:24:12Z | - |
dc.date.issued | 2023-07 | - |
dc.identifier.issn | 0163-2116 | pt |
dc.identifier.issn | 1573-2568 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/112403 | - |
dc.description.abstract | Pancreatic cancer is one of the most fatal malignancies, as approximately 80% of patients are at advanced stages by the time of diagnosis. The main reason for the poor overall survival is late diagnosis that is partially due to the lack of tools for early-stage detection. In addition, there are several challenges in evaluating response to treatment and predicting prognosis. In this article, we do a review of the most common pancreatic cancer biomarkers with emphasis in new and promising approaches. Liquid biopsies seem to have important clinical applications in early detection, screening, prognosis, and longitudinal monitoring of on-treatment patients. Together with biomarkers in imaging, can represent valuable alternative non-invasive tools in order to achieve a more effective management of pancreatic cancer patients. | pt |
dc.language.iso | eng | pt |
dc.publisher | Springer Nature | pt |
dc.relation | Open access funding provided by FCT|FCCN (b-on). | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt |
dc.subject | Pancreatic cancer | pt |
dc.subject | Biomarkers | pt |
dc.subject | Oncogenic mutations | pt |
dc.subject | Liquid biopsies | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Liquid Biopsy | pt |
dc.subject.mesh | Mutation | pt |
dc.subject.mesh | Biomarkers, Tumor | pt |
dc.subject.mesh | Pancreatic Neoplasms | pt |
dc.title | Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review | pt |
dc.type | article | - |
degois.publication.firstPage | 2811 | pt |
degois.publication.lastPage | 2823 | pt |
degois.publication.issue | 7 | pt |
degois.publication.title | Digestive Diseases and Sciences | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1007/s10620-023-07904-6 | pt |
degois.publication.volume | 68 | pt |
dc.date.embargo | 2023-07-01 | * |
uc.date.periodoEmbargo | 0 | pt |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
item.openairetype | article | - |
crisitem.author.orcid | 0000-0002-7494-3218 | - |
crisitem.author.orcid | 0000-0002-7202-8059 | - |
Appears in Collections: | I&D ICBR - Artigos em Revistas Internacionais FMUC Medicina - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pancreatic-Cancer-Biomarkers-Oncogenic-Mutations-Tissue-and-Liquid-Biopsies-and-RadiomicsA-ReviewDigestive-Diseases-and-Sciences.pdf | 737.14 kB | Adobe PDF | View/Open |
Page view(s)
56
checked on Aug 14, 2024
Download(s)
29
checked on Aug 14, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License